Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Class A common stock, par value $0.00001 per share
-
Shares outstanding
-
111M
-
Number of holders
-
253
-
Total 13F shares, excl. options
-
105M
-
Shares change
-
+4.59M
-
Total reported value, excl. options
-
$2.05B
-
Value change
-
+$26.4M
-
Put/Call ratio
-
0.66
-
Number of buys
-
142
-
Number of sells
-
-131
-
Price
-
$19.45
Significant Holders of 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG) as of Q2 2024
322 filings reported holding TXG - 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share as of Q2 2024.
10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG) has 253 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 105M shares
of 111M outstanding shares and own 94.67% of the company stock.
Largest 10 shareholders include FMR LLC (13M shares), VANGUARD GROUP INC (10.2M shares), ARK Investment Management LLC (9.31M shares), BlackRock Inc. (6.39M shares), Nikko Asset Management Americas, Inc. (6.15M shares), Sumitomo Mitsui Trust Holdings, Inc. (6.14M shares), MORGAN STANLEY (5.77M shares), GENERATION INVESTMENT MANAGEMENT LLP (2.88M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.87M shares), and BAILLIE GIFFORD & CO (2.74M shares).
This table shows the top 253 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.